Correlation Between Virpax Pharmaceuticals and Arrowhead Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Virpax Pharmaceuticals and Arrowhead Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virpax Pharmaceuticals and Arrowhead Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virpax Pharmaceuticals and Arrowhead Pharmaceuticals, you can compare the effects of market volatilities on Virpax Pharmaceuticals and Arrowhead Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virpax Pharmaceuticals with a short position of Arrowhead Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virpax Pharmaceuticals and Arrowhead Pharmaceuticals.
Diversification Opportunities for Virpax Pharmaceuticals and Arrowhead Pharmaceuticals
0.69 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Virpax and Arrowhead is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Virpax Pharmaceuticals and Arrowhead Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arrowhead Pharmaceuticals and Virpax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virpax Pharmaceuticals are associated (or correlated) with Arrowhead Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arrowhead Pharmaceuticals has no effect on the direction of Virpax Pharmaceuticals i.e., Virpax Pharmaceuticals and Arrowhead Pharmaceuticals go up and down completely randomly.
Pair Corralation between Virpax Pharmaceuticals and Arrowhead Pharmaceuticals
Given the investment horizon of 90 days Virpax Pharmaceuticals is expected to under-perform the Arrowhead Pharmaceuticals. In addition to that, Virpax Pharmaceuticals is 1.66 times more volatile than Arrowhead Pharmaceuticals. It trades about -0.16 of its total potential returns per unit of risk. Arrowhead Pharmaceuticals is currently generating about -0.1 per unit of volatility. If you would invest 2,018 in Arrowhead Pharmaceuticals on August 27, 2024 and sell it today you would lose (164.00) from holding Arrowhead Pharmaceuticals or give up 8.13% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virpax Pharmaceuticals vs. Arrowhead Pharmaceuticals
Performance |
| Timeline |
| Virpax Pharmaceuticals |
| Arrowhead Pharmaceuticals |
Virpax Pharmaceuticals and Arrowhead Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virpax Pharmaceuticals and Arrowhead Pharmaceuticals
The main advantage of trading using opposite Virpax Pharmaceuticals and Arrowhead Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virpax Pharmaceuticals position performs unexpectedly, Arrowhead Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arrowhead Pharmaceuticals will offset losses from the drop in Arrowhead Pharmaceuticals' long position.| Virpax Pharmaceuticals vs. Revelation Biosciences | Virpax Pharmaceuticals vs. Palisade Bio | Virpax Pharmaceuticals vs. Virax Biolabs Group | Virpax Pharmaceuticals vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |